Document is current
Any future updates will be listed below
-
Authors
Reeves, Carlie
Islam, Rahib K.
Mockbee, Chelsea S.
Helms, Stephen E.
Huynh, Thy N.
Hughes, La’Kitha
Ivory, Deangela M.
Clark, Josh T.
Jackson, Jeremy D.
Brodell, Robert T.
Nahar, Vinayak K.
-
Funding
Funding for this research was provided by:
Health Resources and Services Administration (U66RH31459, U66RH31459, U66RH31459, U66RH31459, U66RH31459)
- License Information
-
More Information
Article History
Received: 15 November 2024
Revised: 12 January 2025
Accepted: 18 January 2025
First Online: 6 February 2025
Declarations
:
: Robert T. Brodell is a principal investigator for clinical trials (Novartis, Lilly and Sanofi), the Corevitas psoriasis biologic registry, Up-to-date Royalties, consulting fee from Amgen, and owns stock in Veradermics, Inc. He is also a staff member at the G.V. (Sonny) Montgomery Veterans Administration Medical Center in Jackson, MS. Carlie Reeves, Rahib K Islam, Chelsea S. Mockbee, Stephen E. Helms, Thy N. Huynh, La’Kitha Hughes, Deangela M. Ivory, Josh T. Clark, Jeremy D. Jackson, Vinayak K. Nahar have no conflicts of interest to disclose.
: This publication/presentation was made possible by the Health Resources and Services Administration (HRSA) of the US Department of Health and Human Services (HHS) as part of the National Telehealth Centers of Excellence Award (U66RH31459). The contents are those of the author(s) and do not necessarily represent the official views of nor an endorsement by the HRSA, HHS, or the US Government.
: The authors declare no competing interests.
